Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $81.13 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $38.51 | 4 | $0 (2021) |
| PFIZER INC. | $28.12 | 1 | $0 (2023) |
| ABBVIE INC. | $14.50 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.12 | 1 | PFIZER INC. ($28.12) |
| 2022 | $14.50 | 1 | ABBVIE INC. ($14.50) |
| 2021 | $38.51 | 4 | Genentech USA, Inc. ($38.51) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Virology & Specialty Care | ||||||
| 10/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Virology & Specialty Care | ||||||
| 02/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Virology & Specialty Care | ||||||
| 01/15/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.73 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 502 | 555 | $115,648 | $27,059 |
| 2022 | 11 | 801 | 866 | $184,067 | $53,775 |
| 2021 | 13 | 1,351 | 1,400 | $211,456 | $91,861 |
| 2020 | 5 | 551 | 578 | $74,237 | $31,910 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 190 | $47,512 | $10,321 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 68 | $23,936 | $5,804 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $22,484 | $4,567 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,312 | $1,669 | 22.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 44 | 47 | $5,311 | $1,627 | 30.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 28 | 28 | $1,736 | $1,135 | 65.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 28 | 56 | $2,800 | $908.32 | 32.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 21 | $2,037 | $478.23 | 23.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 28 | 28 | $1,400 | $453.60 | 32.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 28 | $1,120 | $95.48 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 165 | $57,303 | $16,166 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 227 | $56,060 | $14,775 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 82 | 82 | $25,063 | $6,792 | 27.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 144 | 145 | $14,227 | $6,129 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $16,981 | $5,308 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 28 | $4,289 | $1,421 | 33.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 33 | 70 | $3,500 | $1,137 | 32.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 21 | 23 | $1,426 | $932.65 | 65.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 33 | 33 | $2,939 | $747.90 | 25.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 14 | $679.73 | $228.26 | 33.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 39 | 40 | $1,600 | $137.14 | 8.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 312 | 335 | $71,111 | $25,977 | 36.5% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 401 | 415 | $21,302 | $18,770 | 88.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 139 | $43,869 | $14,319 | 32.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 125 | 125 | $26,594 | $11,984 | 45.1% |
About Emily Reiser, PA-C
Emily Reiser, PA-C is a Physician Assistant healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1659998664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Reiser, PA-C has received a total of $81.13 in payments from pharmaceutical and medical device companies, with $28.12 received in 2023. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($81.13).
As a Medicare-enrolled provider, Reiser has provided services to 3,205 Medicare beneficiaries, totaling 3,399 services with total Medicare billing of $204,604. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Oakhurst, NJ
- Active Since 06/26/2020
- Last Updated 12/19/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659998664
Products in Payments
- Xofluza (Drug) $38.51
- PAXLOVID (Drug) $28.12
- QULIPTA (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oakhurst
Ms. Kadejah Lawrence, Pa-C, PA-C
Physician Assistant — Payments: $1,254
Kathryn Bacci
Physician Assistant — Payments: $724.44
Marie Demasi, Pac, PAC
Physician Assistant — Payments: $250.00
Lindsay Gannon, Pa-C, PA-C
Physician Assistant — Payments: $130.11
Miss. Danielle Defoto, Pa, PA
Physician Assistant — Payments: $114.45
Jeffrey Severino
Physician Assistant — Payments: $50.42